This paradigm would predict that a lack of CFHR proteins (eg, through the common ΔCFHR3/1 allele) would enhance Cfh action and become a protective factor in C3 glomerulopathy or complement-mediated disease in general. Here, CFH is linked to complement 3 glomerulopathy.